• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.对《一项自体树突状细胞疫苗用于新诊断胶质母细胞瘤的大型3期临床试验的生存初步结果》的更正
J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.
2
Correction to: Comparative proteomic analysis of Tibetan pig spermatozoa at high and low altitudes.对《高海拔和低海拔藏猪精子的比较蛋白质组学分析》的更正
BMC Genomics. 2019 Aug 1;20(1):626. doi: 10.1186/s12864-019-5993-6.
3
Correction to: The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies.对《阿片类药物戒断评估的过去、现在与未来:量表与技术的范围综述》的更正
BMC Med Inform Decis Mak. 2019 Jul 8;19(1):126. doi: 10.1186/s12911-019-0851-7.
4
Correction to: ThalPred: a web-based prediction tool for discriminating thalassemia trait and iron deficiency anemia.对《ThalPred:一种用于鉴别地中海贫血特征和缺铁性贫血的基于网络的预测工具》的勘误
BMC Med Inform Decis Mak. 2019 Nov 19;19(1):228. doi: 10.1186/s12911-019-0977-7.
5
Correction to: Hospital organizational context and delivery of evidence-based stroke care: a cross-sectional study.对《医院组织背景与循证卒中护理的提供:一项横断面研究》的更正
Implement Sci. 2019 Feb 8;14(1):13. doi: 10.1186/s13012-019-0862-x.
6
Correction to: Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial.对以下内容的更正:腹股沟淋巴结清扫术后采用预防性、切口负压伤口治疗预防血清肿(血清肿试验):一项随机对照试验的研究方案。
Trials. 2018 Oct 19;19(1):570. doi: 10.1186/s13063-018-2882-2.
7
Correction to: Associations of serum 25-hydroxyvitamin D with metabolic syndrome and its components in elderly men and women: the Korean Urban Rural Elderly cohort study.对《韩国城乡老年人队列研究:老年男性和女性血清25-羟维生素D与代谢综合征及其组分的关联》的更正
BMC Geriatr. 2019 May 8;19(1):131. doi: 10.1186/s12877-019-1150-y.
8
Correction to: Effects of probiotics on type II diabetes mellitus: a meta-analysis.对《益生菌对2型糖尿病的影响:一项荟萃分析》的更正
J Transl Med. 2020 Feb 28;18(1):105. doi: 10.1186/s12967-020-02274-3.
9
Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions.作者更正:大规模全转录组关联研究确定了新的前列腺癌风险区域。
Nat Commun. 2019 Jan 8;10(1):171. doi: 10.1038/s41467-018-08108-7.
10
Correction to: Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project.对《利用卡塔尔生物样本库了解卡塔尔生物样本库首个项目中成年卡塔尔人的2型糖尿病和肥胖症》一文的更正
J Transl Med. 2018 Oct 15;16(1):283. doi: 10.1186/s12967-018-1648-7.

引用本文的文献

1
Immunotherapy in the context of immune-specialized environment of brain metastases.脑转移瘤免疫特异性环境下的免疫治疗
Discov Immunol. 2023 Nov 16;2(1):kyad023. doi: 10.1093/discim/kyad023. eCollection 2023.
2
Drug resistance in glioblastoma: from chemo- to immunotherapy.胶质母细胞瘤中的耐药性:从化疗到免疫治疗
Cancer Drug Resist. 2023 Oct 11;6(4):688-708. doi: 10.20517/cdr.2023.82. eCollection 2023.
3
Application of injectable hydrogels in cancer immunotherapy.可注射水凝胶在癌症免疫治疗中的应用。
Front Bioeng Biotechnol. 2023 Feb 3;11:1121887. doi: 10.3389/fbioe.2023.1121887. eCollection 2023.
4
Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis.主动免疫疗法治疗胶质母细胞瘤的系统评价和荟萃分析。
Cancer Control. 2022 Jan-Dec;29:10732748221079474. doi: 10.1177/10732748221079474.
5
The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis.左乙拉西坦治疗对胶质母细胞瘤患者生存的影响:系统评价和荟萃分析。
J Neurooncol. 2022 Jan;156(2):257-267. doi: 10.1007/s11060-021-03940-2. Epub 2022 Jan 4.
6
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes.免疫治疗早期临床试验与恶性胶质瘤:单中心经验及循环白细胞的全面免疫表型分析
Neurooncol Adv. 2021 Nov 13;3(1):vdab160. doi: 10.1093/noajnl/vdab160. eCollection 2021 Jan-Dec.
7
Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.肿瘤微环境中树突状细胞与自然杀伤细胞之间串扰的表征与调控
Front Immunol. 2021 May 14;12:670540. doi: 10.3389/fimmu.2021.670540. eCollection 2021.
8
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma.免疫检查点抑制剂在胶质母细胞瘤治疗中的现状与未来
Cancer Biol Med. 2020 Aug 15;17(3):555-568. doi: 10.20892/j.issn.2095-3941.2020.0027.
9
Immunotherapy Against Gliomas: is the Breakthrough Near?免疫疗法治疗脑胶质瘤:突破近在咫尺?
Drugs. 2019 Nov;79(17):1839-1848. doi: 10.1007/s40265-019-01203-z.
10
Newly Diagnosed Glioblastoma: A Review on Clinical Management.新诊断的胶质母细胞瘤:临床管理综述。
Oncology (Williston Park). 2019 Mar 13;33(3):91-100.

本文引用的文献

1
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.初现曙光:自体树突状细胞瘤疫苗治疗新诊断胶质母细胞瘤 III 期临床试验的生存结果。
J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6.

对《一项自体树突状细胞疫苗用于新诊断胶质母细胞瘤的大型3期临床试验的生存初步结果》的更正

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

作者信息

Liau Linda M, Ashkan Keyoumars, Tran David D, Campian Jian L, Trusheim John E, Cobbs Charles S, Heth Jason A, Salacz Michael, Taylor Sarah, D'Andre Stacy D, Iwamoto Fabio M, Dropcho Edward J, Moshel Yaron A, Walter Kevin A, Pillainayagam Clement P, Aiken Robert, Chaudhary Rekha, Goldlust Samuel A, Bota Daniela A, Duic Paul, Grewal Jai, Elinzano Heinrich, Toms Steven A, Lillehei Kevin O, Mikkelsen Tom, Walbert Tobias, Abram Steven R, Brenner Andrew J, Brem Steven, Ewend Matthew G, Khagi Simon, Portnow Jana, Kim Lyndon J, Loudon William G, Thompson Reid C, Avigan David E, Fink Karen L, Geoffroy Francois J, Lindhorst Scott, Lutzky Jose, Sloan Andrew E, Schackert Gabriele, Krex Dietmar, Meisel Hans-Jorg, Wu Julian, Davis Raphael P, Duma Christopher, Etame Arnold B, Mathieu David, Kesari Santosh, Piccioni David, Westphal Manfred, Baskin David S, New Pamela Z, Lacroix Michel, May Sven-Axel, Pluard Timothy J, Tse Victor, Green Richard M, Villano John L, Pearlman Michael, Petrecca Kevin, Schulder Michael, Taylor Lynne P, Maida Anthony E, Prins Robert M, Cloughesy Timothy F, Mulholland Paul, Bosch Marnix L

机构信息

University of California Los Angeles (UCLA) David Geffen School of Medicine & Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.

King's College London School of Medical Education, London, UK.

出版信息

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

DOI:10.1186/s12967-018-1552-1
PMID:29958537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6026340/
Abstract

Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and correct author names are indicated and the author name has been updated in the original publication. The authors also reported an error in the Methods section of the original article. In this Correction the incorrect and correct versions of the affected sentence are indicated. The original article has not been updated with regards to the error in the Methods section.

摘要

在原文章[1]发表之后,作者报告了一位作者姓名的拼写错误。在此勘误中,指出了错误的和正确的作者姓名,并且在原出版物中已对作者姓名进行了更新。作者还报告了原文章“方法”部分存在的一个错误。在此勘误中,给出了受影响句子的错误版本和正确版本。关于“方法”部分的错误,原文章未作更新。